• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Pancreatic Cancer Patients with Germline BRCA Mutations Benefit from Early Introduction of Platinum-Based Chemotherapy.

作者信息

Golan Talia, Barenboim Alex, Lubezky Nir

机构信息

Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel.

Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.

出版信息

Ann Surg Oncol. 2020 Oct;27(10):3971-3972. doi: 10.1245/s10434-020-08495-6. Epub 2020 Apr 27.

DOI:10.1245/s10434-020-08495-6
PMID:32342298
Abstract
摘要

相似文献

1
ASO Author Reflections: Pancreatic Cancer Patients with Germline BRCA Mutations Benefit from Early Introduction of Platinum-Based Chemotherapy.ASO作者反思：携带种系BRCA突变的胰腺癌患者受益于早期引入铂类化疗。
Ann Surg Oncol. 2020 Oct;27(10):3971-3972. doi: 10.1245/s10434-020-08495-6. Epub 2020 Apr 27.
2
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis.对于胚系 BRCA 基因 1 和 2 突变的胰腺导管腺癌（PDAC）患者，是否应优先选择基于铂类的化疗？系统评价和荟萃分析。
Cancer Treat Rev. 2019 Nov;80:101895. doi: 10.1016/j.ctrv.2019.101895. Epub 2019 Sep 6.
3
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts.BRCA1和BRCA2突变使源自患者的胰腺癌异种移植瘤对化疗敏感。
Br J Cancer. 2015 Jul 28;113(3):425-32. doi: 10.1038/bjc.2015.220. Epub 2015 Jul 16.
4
BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer.BRCA突变状态与接受铂类化疗的卵巢癌患者血液学毒性增加无关。
Int J Gynecol Cancer. 2018 Jan;28(1):69-76. doi: 10.1097/IGC.0000000000001144.
5
BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.BRCA1/BRCA2 种系突变携带者与散发性胰腺导管腺癌。
J Am Coll Surg. 2018 Apr;226(4):630-637.e1. doi: 10.1016/j.jamcollsurg.2017.12.021. Epub 2018 Jan 5.
6
BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer.BRCA1/2 突变与表达：晚期上皮性卵巢癌患者铂类化疗的反应。
Gynecol Oncol. 2012 Jun;125(3):677-82. doi: 10.1016/j.ygyno.2012.03.006. Epub 2012 Mar 8.
7
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin.聚乙二醇脂质体阿霉素治疗复发性上皮性卵巢癌患者的 BRCA 突变状态和结局决定因素。
Mol Cancer Ther. 2011 Oct;10(10):2000-7. doi: 10.1158/1535-7163.MCT-11-0272. Epub 2011 Aug 11.
8
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.铂类药物初次治疗间隔时间和 BRCA1/2 基因突变状态对复发性卵巢癌患者治疗和生存的影响。
Gynecol Oncol. 2017 Jul;146(1):58-63. doi: 10.1016/j.ygyno.2017.04.011. Epub 2017 Apr 26.
9
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.一种新兴实体：与已知 BRCA 突变相关的胰腺腺癌：临床特征、治疗意义和未来方向。
Oncologist. 2011;16(10):1397-402. doi: 10.1634/theoncologist.2011-0185. Epub 2011 Sep 20.
10
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma.一名67岁女性，患有与胰腺腺癌相关的BRCA 1基因突变。
J Gastrointest Cancer. 2011 Sep;42(3):160-4. doi: 10.1007/s12029-010-9197-1.

引用本文的文献

1
Chemotherapy and radiotherapy for advanced pancreatic cancer.晚期胰腺癌的化疗与放疗
Cochrane Database Syst Rev. 2024 Dec 5;12(12):CD011044. doi: 10.1002/14651858.CD011044.pub3.